EP3758668B1 - Procédé de préparation de microcapsules - Google Patents

Procédé de préparation de microcapsules Download PDF

Info

Publication number
EP3758668B1
EP3758668B1 EP19740583.0A EP19740583A EP3758668B1 EP 3758668 B1 EP3758668 B1 EP 3758668B1 EP 19740583 A EP19740583 A EP 19740583A EP 3758668 B1 EP3758668 B1 EP 3758668B1
Authority
EP
European Patent Office
Prior art keywords
methylene
oil
polyfunctional
microcapsules
process according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
EP19740583.0A
Other languages
German (de)
English (en)
Other versions
EP3758668A1 (fr
Inventor
Lahoussine Ouali
Jean-François BASSET
Laura ETCHENAUSIA
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Firmenich SA
Original Assignee
Firmenich SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Firmenich SA filed Critical Firmenich SA
Publication of EP3758668A1 publication Critical patent/EP3758668A1/fr
Application granted granted Critical
Publication of EP3758668B1 publication Critical patent/EP3758668B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02—Making microcapsules or microballoons
    • B01J13/06—Making microcapsules or microballoons by phase separation
    • B01J13/14—Polymerisation; cross-linking
    • B01J13/16—Interfacial polymerisation
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/26—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests in coated particulate form
    • A01N25/28—Microcapsules or nanocapsules
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/70—Fixation, conservation, or encapsulation of flavouring agents
    • A23L27/72—Encapsulation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • A61K8/068—Microemulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/11—Encapsulated compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/88—Polyamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q13/00—Formulations or additives for perfume preparations
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D17/00—Detergent materials or soaps characterised by their shape or physical properties
    • C11D17/0039—Coated compositions or coated components in the compositions, (micro)capsules
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/50—Perfumes
    • C11D3/502—Protected perfumes
    • C11D3/505—Protected perfumes encapsulated or adsorbed on a carrier, e.g. zeolite or clay

Definitions

  • the present invention relates to a new process for the preparation of core-shell microcapsules.
  • Microcapsules are also an object of the invention.
  • Perfuming compositions and consumer products comprising said capsules, in particular perfumed consumer products in the form of home care or personal care products, are also part of the invention.
  • Polyurea and polyurethane-based microcapsule slurry are widely used for example in perfumery industry as they provide a long lasting pleasant olfactory effect after their applications on different substrates.
  • Those microcapsules have been widely disclosed in the prior art (see for example WO2007/004166 or EP 2300146 from the Applicant). See also WO2013/068255 A1 , WO2013/000587 A1 and WO2013/092958 A1 .
  • microcapsules are known form the prior art, there is still a need to provide new microcapsules while not compromising on their performance, in particular in terms of stability in a consumer product, as well as in delivering a good performance in terms of hydrophobic material delivery.
  • the present invention is proposing a solution to the above-mentioned problem, based on a new process for the preparation of microcapsules.
  • stable core-shell microcapsules encapsulating at least one hydrophobic material could be obtained by reacting a polyfunctional 1,1-disubstituted alkene monomer with a reactant during the process, preferably during the interfacial polymerization to form microcapsules in the form of a slurry.
  • the present invention relates to a process for the preparation of a core-shell microcapsule slurry comprising the steps of:
  • the invention relates to a core-shell microcapsule slurry obtainable by the process as defined above.
  • the invention relates to a core-shell microcapsule slurry comprising at least one microcapsule made of:
  • a composition comprising:
  • Consumer products comprising:
  • Figure 1 is a TGA profile at 50°C of invention's microcapsules.
  • hydrophobic active ingredient it is meant a single compound or a combination of ingredients.
  • perfume or flavour oil it is meant a single perfuming or flavouring compound or a mixture of several perfuming or flavouring compounds.
  • consumer product or "end-product” it is meant a manufactured product ready to be distributed, sold and used by a consumer.
  • dispersion in the present invention it is meant a system in which particles are dispersed in a continuous phase of a different composition and it specifically includes a suspension or an emulsion.
  • polyfunctional monomer it is meant a molecule that, as unit, reacts or binds chemically to form a polymer or supramolecular polymer.
  • the polyfunctional monomer of the invention has at least two functions capable of forming a microcapsule shell.
  • the wording "shell” and “wall” are used indifferently in the present invention.
  • the present invention relates to a process for the preparation of a core-shell microcapsule slurry comprising the steps of:
  • the process for the preparation of a core-shell microcapsule slurry comprises the steps of:
  • an oil phase is formed by admixing at least one hydrophobic material with at least one polyfunctional 1,1-disubstituted alkene monomer.
  • the polyfunctional 1,1-disubstituted alkene monomer comprises at least one 1,1-disubstituted alkene chosen in the group consisting of methylene malonates, methylene ⁇ -ketoesters, methylene ⁇ -diketones, dialkyl disubstituted vinyls, dihaloalkyl disustituted vinyls, and mixtures thereof.
  • the polyfunctional 1,1-disubstituted alkene monomer comprises at least two 1,1-disubstituted alkenes covalently bonded chosen in the group consisting of methylene malonates, methylene ⁇ -ketoesters, methylene ⁇ -diketones, dialkyl disubstituted vinyls, dihaloalkyl disustituted vinyls, and mixtures thereof.
  • the polyfunctional 1,1-disubstituted alkene monomer comprises at least three 1,1-disubstituted alkenes covalently bonded chosen in the group consisting of methylene malonates, methylene ⁇ -ketoesters, methylene ⁇ -diketones, dialkyl disubstituted vinyls, and mixtures thereof.
  • polyfunctional 1,1-disubstituted alkene monomer comprises at least two 1,1-disubstituted alkenes
  • they can be of the same nature or different.
  • the polyfunctional 1,1-disubstituted alkene monomer comprises at least three methylene malonates covalently bonded.
  • the polyfunctional monomer is chosen in the group consisting of O',O'-(2-(((2-(ethoxycarbonyl)acryloyl)oxy)methyl)-2-ethylpropane-1,3-diyl) 3-diethyl bis(2-methylenemalonate), O",O',O-(benzene-1,3,5-triyl) 3-triethyl tris(2-methylenemalonate), 2-ethyl-2-(((2-methylene-3-oxobutanoyl)oxy)methyl)propane-1,3-diyl bis(2-methylene-3-oxobutanoate), O',O-(1,4-phenylenebis(methylene)) 3-diethyl bis(2-methylenemalonate), benzene-1,3,5-triyltris(methylene) tris(2-methylene-3-oxobutanoate), benzene-1,3,5-triyltris(methylene) tris(2-methylene
  • the polyfunctional 1,1-disubstituted alkene monomer comprising at least three methylene malonates is used in combination with a polyfunctional 1,1-disubstituted alkene monomer comprising two methylene malonates.
  • the polyfunctional monomer used in the process according to the invention is present in amounts up to 50%, preferably representing from 0.1 to 15%, more preferably from 0.5 to 10% by weight based on the total weight of the oil phase.
  • the polyfunctional 1,1-disubstituted alkene monomer is prepared by the process comprising the steps of:
  • the polyfunctional 1,1-disubstituted alkene monomer is methylene malonate and is prepared by a process comprising the steps of:
  • the primary or secondary amine is preferably diisopropylammonium 2,2,2-trifluoroacetate.
  • Mannich reaction means an amino alkylation of an acidic proton placed next to a carbonyl functional group with formaldehyde and ammonia or any primary or secondary amine.
  • the Mannich reactions include the reaction between an diisopropylammonium 2,2,2-trifluoroacetate and O,O'-(2-(((3-ethoxy-3-oxopropanoyl)oxy)methyl)-2-ethylpropane-1,3-diyl) diethyl dimalonate, which yields a methylene malonate product.
  • Another object of the invention is a process for preparing a polyfunctional 1,1-disubstituted alkene monomer, said process comprising the steps of:
  • the hydrophobic material according to the invention can be "inert” material like solvents or active ingredients.
  • the hydrophobic material is a hydrophobic active ingredient.
  • hydrophobic active ingredient any hydrophobic active ingredient - single ingredient or a mixture of ingredients - which forms a two-phase dispersion when mixed with water.
  • the hydrophobic active ingredient is liquid at about 20°C.
  • Hydrophobic active ingredients are preferably chosen from the group consisting of flavor, flavor ingredients, perfume, perfume ingredients, nutraceuticals, cosmetics, pest control agents, biocide actives and mixtures thereof.
  • the hydrophobic active ingredient comprises a mixture of a perfume with another ingredient selected from the group consisting of nutraceuticals, cosmetics, pest control agents and biocide actives.
  • the hydrophobic active ingredient comprises a mixture of biocide actives with another ingredient selected from the group consisting of perfume, nutraceuticals, cosmetics, pest control agents.
  • the hydrophobic active ingredient comprises a mixture of pest control agents with another ingredient selected from the group consisting of perfume, nutraceuticals, cosmetics, biocide actives.
  • the hydrophobic active ingredient comprises a perfume.
  • the hydrophobic active ingredient consists of a perfume.
  • the hydrophobic active ingredient consists of biocide actives.
  • the hydrophobic active ingredient consists of pest control agents.
  • perfume an ingredient or composition that is a liquid at about 20°C.
  • said perfume oil can be a perfuming ingredient alone or a mixture of ingredients in the form of a perfuming composition.
  • perfuming ingredient it is meant here a compound, which is used for the primary purpose of conferring or modulating an odour.
  • such an ingredient, to be considered as being a perfuming one must be recognized by a person skilled in the art as being able to at least impart or modify in a positive or pleasant way the odor of a composition, and not just as having an odor.
  • perfume oil also includes combination of perfuming ingredients with substances which together improve, enhance or modify the delivery of the perfuming ingredients, such as perfume precursors, emulsions or dispersions, as well as combinations which impart an additional benefit beyond that of modifying or imparting an odor, such as long-lasting, blooming, malodour counteraction, antimicrobial effect, microbial stability, pest control.
  • perfuming ingredients such as perfume precursors, emulsions or dispersions, as well as combinations which impart an additional benefit beyond that of modifying or imparting an odor, such as long-lasting, blooming, malodour counteraction, antimicrobial effect, microbial stability, pest control.
  • perfuming ingredients present in the oil phase do not warrant a more detailed description here, which in any case would not be exhaustive, the skilled person being able to select them on the basis of its general knowledge and according to intended use or application and the desired organoleptic effect.
  • these perfuming ingredients belong to chemical classes as varied as alcohols, aldehydes, ketones, esters, ethers, acetates, nitriles, terpenoids, nitrogenous or sulphurous heterocyclic compounds and essential oils, and said perfuming co-ingredients can be of natural or synthetic origin. Many of these co-ingredients are in any case listed in reference texts such as the book by S.
  • the perfuming ingredients may be dissolved in a solvent of current use in the perfume industry.
  • the solvent is preferably not an alcohol.
  • solvents are diethyl phthalate, isopropyl myristate, Abalyn ® (rosin resins, available from Eastman), benzyl benzoate, ethyl citrate, limonene or other terpenes, or isoparaffins.
  • the solvent is very hydrophobic and highly sterically hindered, like for example Abalyn ® or benzyl benzoate.
  • the perfume comprises less than 30% of solvent. More preferably the perfume comprises less than 20% and even more preferably less than 10% of solvent, all these percentages being defined by weight relative to the total weight of the perfume. Most preferably, the perfume is essentially free of solvent.
  • biocide refers to a chemical substance capable of killing living organisms (e.g. microorganisms) or reducing or preventing their growth and/or accumulation. Biocides are commonly used in medicine, agriculture, forestry, and in industry where they prevent the fouling of, for example, water, agricultural products including seed, and oil pipelines.
  • a biocide can be a pesticide, including a fungicide, herbicide, insecticide, algicide, molluscicide, miticide and rodenticide; and/or an antimicrobial such as a germicide, antibiotic, antibacterial, antiviral, antifungal, antiprotozoal and/or antiparasite.
  • Pests refer to any living organism, whether animal, plant or fungus, which is invasive or troublesome to plants or animals, pests include insects notably arthropods, mites, spiders, fungi, weeds, bacteria and other microorganisms.
  • the hydrophobic material is free of any active ingredient (such as perfume).
  • it comprises solvents which can form a two-phase dispersion when mixed with water, preferably chosen in the group consisting of isopropyl myristate, tryglycerides (e.g.
  • solvents preferably chosen in the group consisting of 1,4-butanediol, benzyl alcohol, triethyl citrate, triacetin, benzyl acetate, propylene glycol (1,2-propanediol), 1,3-propanediol, dipropylene glycol, glycerol, glycol ethers and mixtures thereof.
  • the hydrophobic material represents between about 10% and 60% w/w, or even between 20% and 45% w/w, by weight, relative to the total weight of the dispersion as obtained after step b).
  • the oil phase essentially consists of polyfunctional monomer of 1,1-disubstituted alkene compound and at least one hydrophobic material.
  • step a) the oil phase of step a) is dispersed into an aqueous solution comprising a colloidal stabilizer to form an oil-in-water emulsion.
  • the colloidal stabilizer used in the present invention can be a molecular colloidal stabilizer or solid particles.
  • the colloidal stabilizer is an ionic colloidal stabilizer chosen in the group consisting of gum Arabic, carboxymethyl cellulose, soy protein, sodium caseinate, gelatin, bovine serum albumin, sugar beet pectin, hydrolyzed soy protein, hydrolyzed sericin, Pseudocollagen, Biopolymer SA-N ((INCI Name: Hyaluronic Acid (and) Albumen (and) Dextran Sulfate; origin Lipo Chemicals), Pentacare-NA PF (INCI Name: Hydrolyzed Wheat Gluten (and) Ceratonia Siliqua (Carob) Gum (and) Aqua (and) Sodium Dextran Sulfate (and) Bis-Hydroxyethyl Tromethamine (and) Phenoxyethanol (and) Ethylhexylglycerin; origin DSM Nutritional Products, LLC), lignin derivatives such as lignosulfonic acid salts and mixtures thereof.
  • the colloidal stabilizer is a non-ionic emulsifier chosen in the group consisting of polyvinyl alcohol, modified polyvinyl alcohol, modified starch, modified cellulose, polysaccharides, lignin, and mixtures thereof.
  • the colloidal stabilizer is chosen in the group consisting of gum Arabic, modified starch, polyvinyl alcohol, polyvinylpyrrolidone (PVP), carboxymethylcellulose (CMC), anionic polysaccharides, acrylamide copolymer, lignin and derivatives, inorganic particles and mixtures thereof.
  • the emulsion comprises between about 0.1% and 5% w/w of at least a colloid stabilizer, percentage being expressed on a w/w basis relative to the total weight of the emulsion as obtained after step b).
  • the emulsion comprises between about 0.1% and 2% w/w of at least a colloid stabilizer.
  • the emulsion may be prepared by high shear mixing and adjusted to the desired droplet size.
  • the mean droplet size of the emulsion is preferably comprised between 1 and 1000 microns, more preferably between 1 and 500 microns, and even more preferably between 5 and 50 microns.
  • the droplet size can be checked with light scattering measurements or microscopy. This procedure does not require a more detailed description here as it is well known to a skilled person in the art.
  • a reactant is added in step a) and/or in step b) and/or in step c).
  • step c) of the process a reactant is added to the oil-in-water emulsion of step b) to induce interfacial polymerization of the polyfunctional 1,1-disubstituted alkene monomer so as to form microcapsules in form of a slurry.
  • nucleophile compounds i . e ., polymerization activator
  • free radical initiator i . e ., polymerization activator
  • a nucleophile compound is defined as a chemical species that donates an electron pair to an electrophile to form a chemical bond in relation to a reaction.
  • the nucleophile compound may be chosen in the group consisting of nitrogen nucleophile, sulfur nucleophile, oxygen nucleophile, carbon nucleophile, phosphor nucleophile, and mixtures thereof.
  • Nitrogen nucleophile compound may have at least one functional group chosen in the group consisting of ammonia, azide, amines, nitrites, hydroxylamine, hydrazin, carbazide, phenylhydrazine, semicarbazide, and amide, and mixtures thereof.
  • Sulfur nucleophile compound may have at least one functional group chosen in the group consisting of hydrogen sulfide and its salts, thiols (RSH), thiolate anions (RS-), anions of thiolcarboxylic acids (RC(O)-S-), and anions of dithiocarbonates (RO-C(S)-S-) and dithiocarbamates (R2N-C(S)-S-) and mixtures therof.
  • RSH thiols
  • RS- thiolate anions
  • R(O)-S- anions of thiolcarboxylic acids
  • R2N-C(S)-S- dithiocarbamates
  • Oxygen nucleophile compound may have at least one functional group chosen in the group consisting of water, hydroxide anion, alcohols, alkoxide anions, carboxylate anions, carbonates, sulfonate, sulfate, sodium phosphates, sodium silicates, borax, sodium tetraborate, and mixtures thereof.
  • Carbone nucleophile compound may have at least one functional group chosen in the group consisting of enols carbon nucleophiles, malonate and acetoacetate.
  • Phosphore nucleophile compound may have at least one functional group chosen in the group consisting of phosphine, phosphite anion and mixture thereof.
  • the reactant is chosen in the group consisting of xylylene diamine, 1,2-diaminocyclohexane, 1,4-diaminocyclohexane, L-lysine, L-Lysine ethyl ester, Jeffamine ® (O,O'-Bis(2-aminopropyl) polypropylene glycol-block-polyethylene glycol-block-polypropylene glycol), ethylene diamine, 1,3-diamino-2-hydroxypropane, diethylene triamine, spermine, spermidine, cystamine, cystine, cystine dialkyl ester, aminoguanidine bicarbonate, N,N'-diethylethylenediamine, polyamidoamine (PAMAM), chitosan, 3-aminopropyltriethoxysilane, L-arginine, 1,3-diaminopropane, N-ethylguanidine sulfate,
  • free radical initiators that can be used in the present invention are peroxides, azo compounds and persulfates. Radicals may be generated by thermal or ambient redox conditions.
  • the wall of the microcapsules is the result of the interfacial polymerization between the polyfunctional 1,1-disubstituted alkene monomer and the reactant, preferably added in step c).
  • the amount of reactant used is typically adjusted so that the molar ratio between the reactive groups of the reactant and the reactive groups of the 1,1-disubstituted alkene monomer is comprised from 0.1 to 10, preferably between 1 and 5.
  • reactive groups of the reactant it is meant nucleophile groups of the reactant as defined previously.
  • reactive groups of the 1,1-disubstituted alkene monomer it is meant methylene group.
  • the reaction is maintained for 2 to 15 hours, more preferably for 2 to 10 hours.
  • said step may be performed at a temperature comprised between 60 and 80°C, possibly under pressure, for 1 to 4 hours. More preferably it is performed at between 50 and 90°C for between 30 minutes and 4 hours.
  • step c) at the end of step c) or during step c), one may also add to the invention's slurry a polymer selected from cationic polymer, a polysaccharide and mixtures thereof to form an outer coating to the microcapsules.
  • Polysaccharide polymers are well known to a person skilled in the art.
  • Preferred non-ionic polysaccharides are selected from the group consisting of locust bean gum, xyloglucan, guar gum, hydroxypropyl guar, hydroxypropyl cellulose and hydroxypropyl methyl cellulose, pectin and mixtures thereof.
  • Cationic polymers are well known to a person skilled in the art.
  • Preferred cationic polymers have cationic charge densities of at least 0.5 meq/g, more preferably at least about 1.5 meq/g, but also preferably less than about 7 meq/g, more preferably less than about 6.2 meq/g.
  • the cationic charge density of the cationic polymers may be determined by the Kjeldahl method as described in the US Pharmacopoeia under chemical tests for Nitrogen determination.
  • the preferred cationic polymers are chosen from those that contain units comprising primary, secondary, tertiary and/or quaternary amine groups that can either form part of the main polymer chain or can be borne by a side substituent directly connected thereto.
  • the weight average (Mw) molecular weight of the cationic polymer is preferably between 10,000 and 3.5M Dalton, more preferably between 50,000 and 1.5M Dalton.
  • Mw weight average molecular weight
  • cationic polymers based on acrylamide, methacrylamide, N-vinylpyrrolidone, quaternized N,N-dimethylaminomethacrylate, diallyldimethylammonium chloride, quaternized vinylimidazole (3-methyl-1-viny1-1H-imidazol-3-ium chloride), vinylpyrrolidone, acrylamidopropyltrimonium chloride, cassia hydroxypropyltrimonium chloride, guar hydroxypropyltrimonium chloride or polygalactomannan 2-hydroxypropyltrimethylammonium chloride ether, starch hydroxypropyltrimonium chloride and cellulose hydroxypropyltrimonium chloride.
  • copolymers shall be selected from the group consisting of polyquaternium-5, polyquaternium-6, polyquaternium-7, polyquatemium10, polyquaternium-11, polyquaternium-16, polyquaternium-22, polyquaternium-28, polyquaternium-43, polyquaternium-44, polyquaternium-46, cassia hydroxypropyltrimonium chloride, guar hydroxypropyltrimonium chloride or polygalactomannan 2-hydroxypropyltrimethylammonium chloride ether, starch hydroxypropyltrimonium chloride and cellulose hydroxypropyltrimonium chloride.
  • Salcare ® SC60 cationic copolymer of acrylamidopropyltrimonium chloride and acrylamide, origin: BASF
  • Luviquat ® such as the PQ 11N, FC 550 or Style (polyquaternium-11 to 68 or quaternized copolymers of vinylpyrrolidone origin: BASF), or also the Jaguar ® (C13S or C17, origin Rhodia).
  • an amount of polymer described above comprised between about 0% and 5% w/w, or even between about 0.1% and 2% w/w, percentage being expressed on a w/w basis relative to the total weight of the slurry as obtained after step c). It is clearly understood by a person skilled in the art that only part of said added polymers will be incorporated into/deposited on the microcapsule shell.
  • Another object of the invention is a process for preparing a microcapsule slurry comprising the steps as defined above and an additional step d) consisting of submitting the slurry obtained in step c) to a drying, like spray-drying, to provide the microcapsules as such, i.e. in a powdery form. It is understood that any standard method known by a person skilled in the art to perform such drying is also applicable.
  • the slurry may be spray-dried preferably in the presence of a polymeric carrier material such as polyvinyl acetate, polyvinyl alcohol, dextrins, natural or modified starch, vegetable gums, pectins, xanthans, alginates, carragenans or cellulose derivatives to provide microcapsules in a powder form.
  • a polymeric carrier material such as polyvinyl acetate, polyvinyl alcohol, dextrins, natural or modified starch, vegetable gums, pectins, xanthans, alginates, carragenans or cellulose derivatives to provide microcapsules in a powder form.
  • drying method such as the extrusion, the fluidized bed, or even a drying at room temperature using materials (carrier, desiccant) that meet specific criteria as disclosed in WO2017/134179 .
  • Another object of the invention is a core-shell microcapsule slurry comprising at least one microcapsule made of:
  • a microcapsule slurry obtainable by the process as described above is also an object of the invention.
  • Still another object of the invention is a microcapsule powder obtained by drying the microcapsules slurry described above.
  • Another object of the invention is a composition
  • a composition comprising
  • Another object of the present invention is a perfuming composition
  • a perfuming composition comprising:
  • liquid perfumery carrier one may cite, as non-limiting examples, an emulsifying system, i.e. a solvent and a surfactant system, or a solvent commonly used in perfumery.
  • a solvent and a surfactant system i.e. a solvent and a surfactant system
  • a detailed description of the nature and type of solvents commonly used in perfumery cannot be exhaustive.
  • solvents such as dipropyleneglycol, diethyl phthalate, isopropyl myristate, benzyl benzoate, 2-(2-ethoxyethoxy)-1-ethanol or ethyl citrate, which are the most commonly used.
  • compositions which comprise both a perfumery carrier and a perfumery co-ingredient can be also ethanol, water/ethanol mixtures, limonene or other terpenes, isoparaffins such as those known under the trademark Isopar ® (origin: Exxon Chemical) or glycol ethers and glycol ether esters such as those known under the trademark Dowanol ® (origin: Dow Chemical Company).
  • perfumery co-ingredient it is meant here a compound, which is used in a perfuming preparation or a composition to impart a hedonic effect and which is not a microcapsule as defined above.
  • perfuming co-ingredients present in the perfuming composition do not warrant a more detailed description here, which in any case would not be exhaustive, the skilled person being able to select them on the basis of his general knowledge and according to the intended use or application and the desired organoleptic effect.
  • these perfuming co-ingredients belong to chemical classes as varied as alcohols, lactones, aldehydes, ketones, esters, ethers, acetates, nitriles, terpenoids, nitrogenous or sulphurous heterocyclic compounds and essential oils, and said perfuming co-ingredients can be of natural or synthetic origin.
  • co-ingredients are in any case listed in reference texts such as the book by S. Arctander, Perfume and Flavor Chemicals, 1969, Montclair, New Jersey, USA , or its more recent versions, or in other works of a similar nature, as well as in the abundant patent literature in the field of perfumery. It is also understood that said co-ingredients may also be compounds known to release in a controlled manner various types of perfuming compounds.
  • perfumery adjuvant we mean here an ingredient capable of imparting additional added benefit such as a color, a particular light resistance, chemical stability, etc.
  • additional added benefit such as a color, a particular light resistance, chemical stability, etc.
  • the perfuming composition according to the invention comprises between 0.1 and 30 % by weight of microcapsules as defined above.
  • microcapsules of the invention can also be added in different perfumed consumer products.
  • a perfuming composition comprising (i) microcapsules as defined above; (ii) at least one perfuming co-ingredient; and (iii) optionally a perfumery adjuvant, is another object of the invention.
  • perfuming co-ingredient it is meant here a compound, which is used in a perfuming preparation or a composition to impart a hedonic effect and which is not a microcapsule as defined above.
  • a co-ingredient to be considered as being a perfuming one, must be recognized by a person skilled in the art as being able to impart or modify in a positive or pleasant way the odor of a composition, and not just as having an odor.
  • perfuming co-ingredients present in the perfuming composition do not warrant a more detailed description here, which in any case would not be exhaustive, the skilled person being able to select them on the basis of his general knowledge and according to the intended use or application and the desired organoleptic effect.
  • these perfuming co-ingredients belong to chemical classes as varied as alcohols, lactones, aldehydes, ketones, esters, ethers, acetates, nitriles, terpenoids, nitrogenous or sulphurous heterocyclic compounds and essential oils, and said perfuming co-ingredients can be of natural or synthetic origin.
  • co-ingredients are in any case listed in reference texts such as the book by S. Arctander, Perfume and Flavor Chemicals, 1969, Montclair, New Jersey, USA , or its more recent versions, or in other works of a similar nature, as well as in the abundant patent literature in the field of perfumery. It is also understood that said co-ingredients may also be compounds known to release in a controlled manner various types of perfuming compounds.
  • perfumery adjuvant we mean here an ingredient capable of imparting additional added benefit such as a color, a particular light resistance, chemical stability, etc.
  • additional added benefit such as a color, a particular light resistance, chemical stability, etc.
  • the perfuming composition according to the invention comprises between 0.1 and 30 % by weight of microcapsules as defined above.
  • microcapsules can advantageously be used in many application fields and used in consumer products.
  • Microcapsules can be used in liquid form applicable to liquid consumer products as well as in powder form, applicable to powder consumer products.
  • the products of the invention can in particular be of used in perfumed consumer products such as product belonging to fine fragrance or "functional" perfumery.
  • Functional perfumery includes in particular personal-care products including hair-care, body cleansing, skin care, hygiene-care as well as home-care products including laundry care and air care.
  • another object of the present invention consists of a perfumed consumer product comprising as a perfuming ingredient, the microcapsules defined above or a perfuming composition as defined above.
  • the perfume element of said consumer product can be a combination of perfume microcapsules as defined above and free or non-encapsulated perfume, as well as other types of perfume microcapsule than those here-disclosed.
  • liquid consumer product comprising:
  • inventions microcapsules can therefore be added as such or as part of an invention's perfuming composition in a perfumed consumer product.
  • perfumed consumer product it is meant a consumer product which is expected to deliver among different benefits a perfuming effect to the surface to which it is applied (e.g. skin, hair, textile, paper, or home surface) or in the air (air-freshener, deodorizer etc).
  • a perfumed consumer product according to the invention is a manufactured product which comprises a functional formulation also referred to as "base”, together with benefit agents, among which an effective amount of microcapsules according to the invention.
  • Non-limiting examples of suitable perfumed consumer product can be a perfume, such as a fine perfume, a cologne, an after-shave lotion, a body-splash; a fabric care product, such as a liquid or solid detergent, tablets and pods, a fabric softener, a dryer sheet, a fabric refresher, an ironing water, or a bleach; a personal-care product, such as a hair-care product (e.g. a shampoo, hair conditioner, a colouring preparation or a hair spray), a cosmetic preparation (e.g. a vanishing cream, body lotion or a deodorant or antiperspirant), or a skin-care product (e.g.
  • a hair-care product e.g. a shampoo, hair conditioner, a colouring preparation or a hair spray
  • a cosmetic preparation e.g. a vanishing cream, body lotion or a deodorant or antiperspirant
  • a skin-care product e.g.
  • a perfumed soap, shower or bath mousse, body wash, oil or gel, bath salts, or a hygiene product a perfumed soap, shower or bath mousse, body wash, oil or gel, bath salts, or a hygiene product
  • an air care product such as an air freshener or a "ready to use” powdered air freshener
  • a home care product such all-purpose cleaners, liquid or power or tablet dishwashing products, toilet cleaners or products for cleaning various surfaces, for example sprays & wipes intended for the treatment / refreshment of textiles or hard surfaces (floors, tiles, stone-floors etc.); a hygiene product such as sanitary napkins, diapers, toilet paper.
  • Another object of the invention is a consumer product comprising:
  • the personal care composition is preferably chosen in the group consisting of a hair-care product (e.g. a shampoo, hair conditioner, a colouring preparation or a hair spray), a cosmetic preparation (e.g. a vanishing cream, body lotion or a deodorant or antiperspirant), or a skin-care product (e.g. a perfumed soap, shower or bath mousse, body wash, oil or gel, bath salts, or a hygiene product).
  • a hair-care product e.g. a shampoo, hair conditioner, a colouring preparation or a hair spray
  • a cosmetic preparation e.g. a vanishing cream, body lotion or a deodorant or antiperspirant
  • a skin-care product e.g. a perfumed soap, shower or bath mousse, body wash, oil or gel, bath salts, or a hygiene product.
  • Another object of the invention is a consumer product comprising:
  • the home or fabric care composition is preferably chosen in the group consisting fabric softener, liquid detergent, powder detergent, liquid scent booster solid scent booster.
  • the consumer product is in the form of a fabric softener composition and comprises:
  • the fabric softener active base may comprise cationic surfactants of quaternary ammonium, such as Dialkyl ester dimethyl ammonium chloride (DEEDMAC), TEAQ (triethanolamine quat), HEQ (Hamburg esterquat), and mixtures thereof.
  • quaternary ammonium such as Dialkyl ester dimethyl ammonium chloride (DEEDMAC), TEAQ (triethanolamine quat), HEQ (Hamburg esterquat), and mixtures thereof.
  • the consumer product comprises from 0.1 to 15 wt%, more preferably between 0.2 and 5 wt% of the microcapsules of the present invention, these percentages being defined by weight relative to the total weight of the consumer product.
  • concentrations may be adapted according to the benefit effect desired in each product.
  • Trimethylolpropane (1.1 g, 8.20 mmol) is added to xylene (10 ml, 27.0 mmol) and the solution is heated to 125°C.
  • 2,2,6-Trimethyl-4H-1,3-dioxin-4-one (6.13 g, 41.0 mmol) is added slowly (2.5ml/h). The mixture is kept at 125°C in an open flask.
  • 1,4-phenylenedimethanol (2g, 14.48 mmol) , ethyl malonyl monochloride (5.56 ml, 43.4 mmol) , and pyridine (3.51 ml, 43.4 mmol) were mixed in dichloromethane (214 ml, 3329 mmol) / tetrahydrofuran (35.6 ml, 434 mmol) and the solution was stirred for 12 h at 20°C. The mixture was washed with saturated aqueous NH 4 Cl solution (2 ⁇ ), dried (Na 2 SO 4 ), and evaporated to dryness. Column chromatography (S i O 2 ;CH 2 Cl 2 /AcOEt 3:1) yielded the desired product as a colorless oil.
  • Microcapsules A-G were prepared according to the following protocol.
  • aqueous solution of stabilizer is prepared by dissolving 2 wt% of Gum Arabic Superstab AA (origin: Nexira, France) in deionized water.
  • the oil phase is formulated by dissolving monomers (as prepared in example 1 (TriDEMM), 2 (aromatic TriDEMM), 3 (triacetoacetate) or 4 (aromatic diDEMM)) in a perfume oil A (see table 1) or in a solvent.
  • the oil phase is poured into the water phase and the mixture is emulsified with an Ultra-Turrax disperser at 24 000 rpm for 30s to form the oil-in-water emulsion.
  • the emulsion is introduced into a jacketed reactor, fitted with a reflux condenser and stainless steel stirrer, and stirred at 400 rpm.
  • an aqueous solution of tris(2-aminoethyl)amine (origin: Alfa Aesar, Switzerland) is prepared and added dropwise to the oil-in-water emulsion.
  • the reaction mixture is stirred at room temperature for at least 2 hours or at 60°C for 2 hours.
  • the final product is recovered as a milky dispersion.
  • Table 1 Perfume oil A composition Raw material wt% Romascone ® a) 33.3 Verdox TMb) 33.3 Lorysia ® c) 33.3 a) Methyl 2,2-dimethyl-6-methylene-1-cyclohexanecarboxylate, origin: Firmenich SA, Geneva, Switzerland b) 2-tert-butyl-1-cyclohexyl acetate, trademark from International Flavors & Fragrances, USA c) 4-(1,1-dimethylethyl)-1-cyclohexyl acetate, origin: Firmenich SA, Geneva, Switzerland
  • Table 2 Microcapsule compositions (based on triDEMM - prepared according to example 1) Capsules triDEMM (g) triamine (g) Perfume (g) Gum arabic solution at 2 wt% (g) [NH 2 ]/[double bond] (mol/mol) triDEMM/perfume (g/g) A 3.835 1.65 59.12
  • Shell were extracted and analyzed by elemental analysis. Composition was estimated by calculation based on the component compositions. Table 6: Composition of the extracted and purified shell of capsule A (example 5) determined by elemental analysis Capsules %C %H %N %O A 53.0 6.5 3.4 34.6
  • TGA Capsule performance was assessed at 50°C with a thermogravimetric analyser (TGA/SDTA851e, Origin: Mettler-Toledo, Switzerland) equipped with a microbalance (accuracy: 1 ⁇ g) and an accurate oven having an internal volume of 35 ml, under a constant nitrogen flow of 20ml/min. Perfume evaporation was measured as a function of time. Microcapsules dispersion (10 mg) was introduced in alumina pan of 100 ⁇ l. The measurement at 50°C started from 25°C to 50°C at 5°C/min, and then staid at 50°C for 4 h. A slower evaporation of the perfume oil with a long-lasting profile was related to a more stable capsule.
  • Figure 1 shows that microcapsules A are stable.
  • Capsules A, B, C or D of the present invention are dispersed in a fabric softener base described in table 7 to obtain a concentration of encapsulated perfume oil at 0.22%.
  • Table 7 Fabric Softener composition Product Wt % Stepantex VL 90A 8.88 Calcium Chloride Sol. 10% 0.36 Proxel GXL 0.04 Perfume 1 Water 89.72 TOTAL 100
  • Capsules A, B, C or D of the present invention are dispersed in a liquid detergent base described in table 8 to obtain a concentration of encapsulated perfume oil at 0.22%.
  • Table 8 Liquid detergent composition Ingredients Concentration [wt%] Sodium C14-17 Alkyl Sec Sulfonate 1) 7 Fatty acids, C12-18 and C18-unsaturated 2) 7.5 C12/14 fatty alcohol polyglycol ether with 7 mol EO 3) 17 Triethanolamine 7.5 Propylene Glycol 11 Citric acid 6.5 Potassium Hydroxyde 9.5 Protease 0.2 Amylase 0.2 Mannanase 0.2 Acrylates/Steareth-20 Methacrylate structuring Crosspolymer 4) 6 Deionized Water 27.4
  • Capsules A, B, C or D of the present invention are dispersed in a rinse-off conditioner base described in table 9 to obtain a concentration of encapsulated perfume oil at 0.5%.
  • Table 9 Rinse-off conditioner composition Ingredients Concentration [wt%] A Water deionized 81.8 Behentrimonium Chloride 1) 2.5 Hydroxyethylcellulose 2) 1.5 B Cetearyl Alcohol 3) 4 Glyceryl Stearate (and) PEG-100 Stearate 4) 2 Behentrimonium Methosulfate (and) Cetyl alcohol (and) Butylene Glycol 5) 4 Ethoxy (20) Stearyl Alcohol 6) 1 C Amodimethicone (and) Trideceth-12 (and) Cetrimonium Chloride 7) 3 Chlorhexidine Digluconate 8) 20% aqueous solution 0.2 D Citric acid 10% aqueous sol. till pH 3.5-4 q.s. TOTAL: 100

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Zoology (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Dentistry (AREA)
  • Agronomy & Crop Science (AREA)
  • Environmental Sciences (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Cosmetics (AREA)
  • Fats And Perfumes (AREA)
  • Manufacturing Of Micro-Capsules (AREA)

Claims (15)

  1. Procédé de préparation d'une suspension épaisse de microcapsules à noyau-enveloppe, comprenant les étapes consistant à :
    a) mélanger au moins un matériau hydrophobe avec au moins un monomère alcène 1,1-disubstitué polyfonctionnel pour former une phase huileuse ;
    b) ajouter la phase huileuse dans une phase aqueuse comprenant un stabilisant colloïdal pour former une émulsions huile-dans-eau ;
    c) appliquer des conditions suffisantes pour induire une polymérisation interfaciale du monomère alcène 1,1-disubstitué polyfonctionnel de façon à former des microcapsules sous la forme d'une suspension épaisse,
    dans lequel un réactif est ajouté à l'étape a) et/ou l'étape b) et/ou l'étape c).
  2. Procédé selon la revendication 1 dans lequel le monomère alcène 1,1-disubstitué polyfonctionnel comprend au moins un alcène 1,1-disubstitué choisi dans le groupe constitué par les méthylènemalonates, les méthylène-β-cétoesters, les méthylène-β-dicétones, les dialkylvinyles disubstitués, les dihalogénoalkylvinyles disubstitués, et des mélanges de ceux-ci.
  3. Procédé selon la revendication 1 ou 2 dans lequel le monomère alcène 1,1-disubstitué polyfonctionnel comprend au moins trois méthylènemalonates liés par covalence.
  4. Procédé selon la revendication 2 ou 3 dans lequel le monomère polyfonctionnel est choisi dans le groupe constitué par le O',O'-(2-(((2-(éthoxycarbonyl)acryloyl)oxy)méthyl)-2-éthylpropane-1,3-diyl)-3-diéthyl-bis(2-méthylènemalonate), le O",O',O-(benzène-1,3,5-triyl)-3-triéthyl-tris(2-méthylènemalonate), le 2-éthyl-2-(((2-méthylène-3-oxobutanoyl)oxy)méthyl)propane-1,3-diyl-bis(2-méthylène-3-oxobutanoate), le O',O-(1,-phénylènebis(méthylène))-3-diéthyl-bis(2-méthylènemalonate), le benzène-1,3,5-triyltris(méthylène)tris(2-méthylène-3-oxobutanoate), le benzène-1,3,5-triyltris(méthylène)tris(2-méthylène-3-oxopentanoate) et des mélanges de ceux-ci.
  5. Procédé selon l'une quelconque des revendications précédentes, dans lequel le stabilisant colloïdal est choisi dans le groupe constitué par la gomme arabique, l'amidon modifié, l'alcool polyvinylique, la polyvinylpyrrolidone, la carboxyméthylcellulose, les polysaccharides anioniques, un copolymère d'acrylamide, la lignine et des dérivés de celle-ci, des particules inorganiques, et des mélanges de ceux-ci.
  6. Procédé selon l'une quelconque des revendications précédentes, dans lequel le réactif est un composé nucléophile choisi dans le groupe constitué par un nucléophile azoté, un nucléophile soufré, un nucléophile carboné, un nucléophile oxygéné, un nucléophile phosphoré, et des mélanges de ceux-ci.
  7. Procédé selon l'une quelconque des revendications précédentes, dans lequel le réactif est choisi dans le groupe constitué par la xylylènediamine, le 1,2-diaminocyclohexane, le 1,4-diaminocyclohexane, la L-lysine, l'ester éthylique de L-lysine, le O,O'-bis(2-aminopropyl)polypropylèneglycol-bloc-polyéthylèneglycol-bloc-polypropylèneglycol, l'éthylènediamine, le 1,3-diamino-2-hydroxypropane, la diéthylènetriamine, la spermine, la spermidine, la cystamine, la cystine, un ester dialkylique de cystine, le bicarbonate d'aminoguanidine, la N,N'-diéthyléthylènediamine, la polyamidoamine (PAMAM), le chitosane, le 3-aminopropyltriéthoxysilane, la L-arginine, le 1,3-diaminopropane, le sulfate de N-éthylguanidine, le 1,6-diaminohexane, les sels de guanidine, la N,N,N',N'-tétrakis(3-aminopropyl)-1,4-butanediamine, le guanazole, le 2-amino-1,3-propanediol, l'éthanolamine, la tris(2-aminoéthyl)amine, la tris(3-aminopropyl)amine, la tris[2-(méthylamino)éthyl]amine, la 1-(2-aminoéthyl)pipérazine, la triéthylènetétramine, la triéthanolamine, le sel dipotassique de l'acide phtalique, le sel disodique de l'acide succinique, le dithiothréitol, le tris(3-mercaptopropionate) de triméthylolpropane, le tétrakis(3-mercaptopropionate) de pentaérythritol, le 2,2'-thiodiéthanethiol et des mélanges de ceux-ci.
  8. Procédé selon l'une quelconque des revendications précédentes, dans lequel le monomère alcène 1,1-disubstitué polyfonctionnel est ajouté en une quantité allant jusqu'à 50% en poids, par rapport au poids total de la phase huileuse.
  9. Procédé selon l'une quelconque des revendications précédentes, dans lequel le réactif est ajouté en une quantité allant jusqu'à 60% en poids, par rapport au poids total de la dispersion huile-dans-eau.
  10. Procédé selon l'une quelconque des revendications précédentes, dans lequel l'ingrédient actif hydrophobe est une huile de parfum.
  11. Suspension épaisse de microcapsules à noyau-enveloppe, pouvant être obtenue par le procédé tel que décrit dans l'une quelconque des revendications 1 à 10.
  12. Suspension épaisse de microcapsules à noyau-enveloppe, comprenant au moins une microcapsule constituée de :
    - un noyau liquide, de préférence un noyau à base d'huile, et
    - une enveloppe comprenant au moins un monomère alcène 1,1-disubstitué polyfonctionnel polymérisé.
  13. Composition parfumante comprenant
    (i) une suspension épaisse de microcapsules de parfum telle que définie dans la revendication 11 ou 12, dans laquelle le noyau à base d'huile comprend un parfum,
    (ii) au moins un ingrédient sélectionné dans le groupe constitué par un support de parfumerie et une base de parfumerie
    (iii) facultativement, au moins un adjuvant d'usage courant en parfumerie.
  14. Produit de consommation comprenant :
    - une base active pour soins corporels, et
    - des microcapsules telles que définies dans les revendications 11 ou 12 ou la composition parfumante telle que définie dans la revendication 13,
    où le produit de consommation est sous la forme d'une composition de soins corporels.
  15. Produit de consommation comprenant:
    - une base active pour l'entretien ménager ou l'entretien textile, et
    - des microcapsules telles que définies dans les revendications 11 ou 12 ou la composition parfumante telle que définie dans la revendication 13,
    où le produit de consommation est sous la forme d'une composition pour l'entretien ménager ou l'entretien textile.
EP19740583.0A 2018-07-25 2019-07-22 Procédé de préparation de microcapsules Active EP3758668B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18185415 2018-07-25
PCT/EP2019/069690 WO2020020829A1 (fr) 2018-07-25 2019-07-22 Procédé de préparation de microcapsules

Publications (2)

Publication Number Publication Date
EP3758668A1 EP3758668A1 (fr) 2021-01-06
EP3758668B1 true EP3758668B1 (fr) 2022-02-23

Family

ID=63047174

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19740583.0A Active EP3758668B1 (fr) 2018-07-25 2019-07-22 Procédé de préparation de microcapsules

Country Status (7)

Country Link
US (1) US20210129104A1 (fr)
EP (1) EP3758668B1 (fr)
JP (1) JP7369711B2 (fr)
CN (1) CN112055580B (fr)
MX (1) MX2020010192A (fr)
SG (1) SG11202009432PA (fr)
WO (1) WO2020020829A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2946614T3 (es) 2020-04-21 2023-07-21 Takasago Perfumery Co Ltd Composición de fragancia
EP3900696B1 (fr) 2020-04-21 2023-04-19 Takasago International Corporation Composition de parfum encapsulée
EP4263487A1 (fr) * 2020-12-17 2023-10-25 The Royal Institution for the Advancement of Learning / McGill University Additifs chimiques et leur utilisation dans le but de modifier les propriétés mécaniques du pvc et d'empêcher la formation de défauts de surface pendant le calandrage du pvc

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL239541A (fr) * 1958-06-04
US3427250A (en) * 1963-03-25 1969-02-11 Polaroid Corp Microscopic capsules and process for their preparation
FR2778100B1 (fr) * 1998-04-29 2001-05-04 Virsol Nouvelles microspheres a base de poly(methylidene malonate), leur procede de preparation et compositions pharmaceutiques les contenant
DE10013850A1 (de) * 2000-03-15 2001-09-20 Schering Ag Gasgefüllte Mikrokapseln enthaltend funktionalisiertes Polyalkylcyanacrylat, sowie Verfahren zu deren Herstellung
KR100868512B1 (ko) * 2002-05-24 2008-11-12 마쓰모토유시세이야쿠 가부시키가이샤 열팽창성 마이크로 캡슐 및 그 이용
WO2007004166A1 (fr) 2005-06-30 2007-01-11 Firmenich Sa Microcapsules de polyurethane et de polyuree
GB0623110D0 (en) * 2006-11-21 2006-12-27 Ciba Sc Holding Ag Microcapules, their use and processes for their manufacture
EP2300146B1 (fr) 2008-06-16 2017-03-29 Firmenich S.A. Procédé de préparation de microcapsules de polyurée
CN101306341B (zh) * 2008-07-02 2011-03-23 深圳先进技术研究院 一种界面聚合法制备的相变储能微胶囊及其方法
JP6012724B2 (ja) * 2011-06-28 2016-10-25 フイルメニツヒ ソシエテ アノニムＦｉｒｍｅｎｉｃｈ Ｓａ ポリ尿素マイクロカプセルの製造方法
US9358189B2 (en) * 2011-11-10 2016-06-07 Firmenich Sa Stable formaldehyde-free microcapsules
KR20140107571A (ko) * 2011-12-22 2014-09-04 지보당 에스아 향수의 캡슐화에서의 또는 그와 관련된 개선
JP5992547B2 (ja) * 2015-01-08 2016-09-14 積水化成品工業株式会社 マイクロカプセル粒子の製造方法及び中空粒子の製造方法
US9334430B1 (en) * 2015-05-29 2016-05-10 Sirrus, Inc. Encapsulated polymerization initiators, polymerization systems and methods using the same
CN108602040A (zh) 2016-02-02 2018-09-28 弗门尼舍有限公司 在室温下干燥悬浮液的方法
CN110036038B (zh) * 2016-12-16 2021-11-05 花王株式会社 微胶囊的制造方法

Also Published As

Publication number Publication date
SG11202009432PA (en) 2020-10-29
MX2020010192A (es) 2020-10-20
CN112055580A (zh) 2020-12-08
JP7369711B2 (ja) 2023-10-26
CN112055580B (zh) 2024-01-09
WO2020020829A1 (fr) 2020-01-30
JP2021531950A (ja) 2021-11-25
US20210129104A1 (en) 2021-05-06
EP3758668A1 (fr) 2021-01-06

Similar Documents

Publication Publication Date Title
JP6890592B2 (ja) 改善された付着性を有するポリ尿素マイクロカプセルの製造方法
JP6861629B2 (ja) 付着が改善されたポリ尿素マイクロカプセルの製造方法
EP3758668B1 (fr) Procédé de préparation de microcapsules
EP3894064B1 (fr) Procédé de préparation de microcapsules
JP2021516603A (ja) マイクロカプセルの製造方法
EP3897956A1 (fr) Microcapsules de polyamide
CN113195091A (zh) 制备聚酰胺微胶囊的方法
EP3894063B1 (fr) Microcapsules de poly(ester-urée)
EP3921075B1 (fr) Microcapsules clivables à base de plusieurs alcools
US11666881B2 (en) Process for preparing polysuccinimide derivatives-based microcapsules
JP2021517112A (ja) 付着性が改善されたマイクロカプセルを製造する方法
CN117098598A (zh) 交联的核-壳微胶囊
JP2023529517A (ja) ポリアミドマイクロカプセル
EP4351775A1 (fr) Microcapsules à base de polyamide
BR112021011448B1 (pt) Microcápsulas de poliamida

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: UNKNOWN

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20201001

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
INTG Intention to grant announced

Effective date: 20211029

RIN1 Information on inventor provided before grant (corrected)

Inventor name: ETCHENAUSIA, LAURA

Inventor name: BASSET, JEAN-FRANCOIS

Inventor name: OUALI, LAHOUSSINE

RAP3 Party data changed (applicant data changed or rights of an application transferred)

Owner name: FIRMENICH SA

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 1469882

Country of ref document: AT

Kind code of ref document: T

Effective date: 20220315

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602019011931

Country of ref document: DE

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG9D

REG Reference to a national code

Ref country code: NL

Ref legal event code: MP

Effective date: 20220223

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 1469882

Country of ref document: AT

Kind code of ref document: T

Effective date: 20220223

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220223

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220223

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220623

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220523

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220223

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220223

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220223

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220223

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220523

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220223

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220223

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220524

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220223

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220223

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220623

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220223

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220223

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220223

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220223

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220223

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220223

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602019011931

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220223

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed

Effective date: 20221124

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220223

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220223

REG Reference to a national code

Ref country code: BE

Ref legal event code: MM

Effective date: 20220731

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20220722

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20220731

P01 Opt-out of the competence of the unified patent court (upc) registered

Effective date: 20230518

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220223

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20220722

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20230622

Year of fee payment: 5

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20230601

Year of fee payment: 5

Ref country code: CH

Payment date: 20230801

Year of fee payment: 5

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20230531

Year of fee payment: 5

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220223

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220223

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20190722